News
The string of approvals and acquisitions in the microinvasive glaucoma surgery space has been one of ophthalmology’s more promising stories. The news shone a bright…
Read More
Shire Makes Xiidra Available in US With FDA approval of Xiidra (liftegrast) in hand, its dry eye challenger to Allergan’s Restasis (cyclosporine), the next step…
Read More
The FDA approval last week of Xiidra (lifitegrast ophthalmic solution) from Shire plc represents a major milestone for the dry eye market. Restasis, which was…
Read More
Retinal disease remains a challenging target for drug and device makers, but a panel of senior executives at last week’s OIS@ASRS says the potential benefits…
Read More
A new Ophthalmology Innovation Summit emerged Monday just prior to the start of the annual meeting of the American Society of Retina Specialists. The half-day…
Read More
In this week’s OIS Podcast, we spoke with Jim Mazzo, the head of Carl Zeiss Meditec’s new ophthalmology unit. In the podcast, Mazzo hits upon…
Read More
CyPass Micro-Stent Gets FDA Thumbs Up The FDA topped off a busy month of ophthalmic approvals last week with its blessing of the CyPass Micro-Stent…
Read More
Carl Zeiss Meditec has moved to consolidate its diagnostic and surgical products in ophthalmology and has brought in well-known ophthalmology industry veteran, James V. Mazzo,…
Read More
Google’s DeepMind Health artificial intelligence project and Moorfields Eye Hospital in London have teamed up for a five-year venture to develop an algorithm using one…
Read More
One of the takeaways that ophthalmic innovators might be reading into the unexpected and somewhat sudden approval of the Raindrop Near Vision Inlay is that…
Read More
With the FDA’s approval last week of Abbott Medical Optics’ Tecnis Symfony IOL (intraocular lens), cataract and refractive surgeons have a new alternative to monovision…
Read More
Two years ago, Robert Dempsey joined Shire to build the pharma giant’s new ophthalmology unit. Rather than acquire a portfolio of established products to build…
Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
![OIS-ANTERIOR-NEW-DATE-750x420[4300]](https://ois.net/wp-content/uploads/2020/03/OIS-ANTERIOR-NEW-DATE-750x4204300.jpg "OIS-ANTERIOR-NEW-DATE-750x420[4300]")